Pharbetol
- Product NDC
- 17856-0353
- 11-digit product format
- 178560353
- Labeler code
- 17856
- Product ID
- 17856-0353_36d8e8fb-3928-ffbe-e063-6394a90a5779
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Application
- M
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2007-01-09
- Substance
- ACETAMINOPHEN
- Active strength
- 325 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 17856-0353 | I | Inactivated by FDA | 2026-10-12 | ||
| excluded package | package | 17856-0353 | 17856-0353-3 | I | Inactivated by FDA | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 17856-0353-1 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 17856-0353-1 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 17856-0353-1 | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pharbetol
- Brand name suffix
- Regular strength
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 325 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 05a91d24-b498-4ba2-a275-68b871cf62d2 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Menthol Pain Relieving Cream with Menthol 10% | MENTHOL 10% CREAM | ONE2ZEE LIMITED LIABILITY COMPANY | ae09e93f-3988-4477-ae53-b2f3df9769fb | 2025-05-05 | Warnings | M |
| Anua Zero-Cast Moisturizing Finish Sunscreen SPF 50 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | ENGLEWOOD LAB, INC. | edf07b7f-46fb-4915-b2ea-83d852617f60 | 2025-04-10 | Warnings | M |
| BRONCOCHEM KIDS COLD AND FLU | ACETAMINOPHEN-PHENYLEPHRINE HCL-GUAIFENESIN | LABORATORIO MAGNACHEM INTERNATIONAL SRL | b6559fb9-2dea-49c0-a274-3e77741a0ffd | 2025-03-23 | Warnings | M |
| BRONCOCHEM MAXIMUM COUGH | DEXTROMETHORPHAN HBR-GYAIFENESIN | LABORATORIO MAGNACHEM INTERNATIONAL SRL | deecdb72-4cdb-4d6f-972f-a425a91afa5a | 2025-03-23 | Warnings | M |
| BRONCOCHEM MAXIMUM COUGH NIGHT | DEXTROMETHORPHAN HBR-PYRILAMINE MALEATE | LABORATORIO MAGNACHEM INTERNATIONAL SRL | dffdfa2c-a52e-4606-9b07-c8993e499f09 | 2025-03-23 | Warnings | M |
| BRONCOCHEM EXPECTORANT II | ACETAMINOPHEN-CHLORPHENIRAMINE MALEATE-DEXTROMETHORPHAN HBR-GUAIFENESIN-PHENYLEPHRINE HCL | LABORATORIO MAGNACHEM INTERNATIONAL SRL | 1fb86dcb-6f51-4c29-99ad-a5a9b7b7526a | 2025-03-23 | Warnings | M |
| BRONCOCHEM MAXIMUM COUGH KIDS | DEXTROMETHORPHAN HBR-GUAIFENESIN | LABORATORIO MAGNACHEM INTERNATIONAL SRL | b0fd2f2f-5cc4-4813-8f99-c78fbe898656 | 2025-03-13 | Warnings | M |
| Menthol Pain Relief Gel Patch | MENTHOL PAIN RELIEF GEL PATCH | ONE2ZEE LIMITED LIABILITY COMPANY | eab185d6-2a54-489d-8114-fe8088624ba4 | 2025-03-04 | Warnings | M |
| Lidocaine 4% Pain Relief Gel Patch | LIDOCAINE 4% PAIN RELIEF GEL PATCH | ONE2ZEE LIMITED LIABILITY COMPANY | 8e5a4ef4-b928-44b3-842c-92f1531af75b | 2025-03-03 | Warnings | M |
| gas relief | SIMETHICONE | Strategic Sourcing Services LLC | 23005295-c5f2-4a76-8431-4a9b8d817d4d | 2025-01-03 | Warnings | M |
| Foster and Thrive infants Gas relief | SIMETHICONE | Strategic Sourcing Services LLC | 824c9dff-0a26-4710-a25b-39df631d6fa6 | 2024-12-13 | Warnings | M |
| BRONCOCHEM COLD AND FLU TEA | ACETAMINOPHEN-PHENYLEPHRINE HYDROCHLORIDE-CHLORPHENIRAMINE MALEATE | LABORATORIO MAGNACHEM INTERNATIONAL SRL | b7d3f54e-59ef-4b85-a88d-b053058dc1f6 | 2024-12-12 | Warnings | M |
| HYSAN PAIN RELIEVER | METHYL SALICYLATE, CAMPHOR (SYNTHETIC) | HYSAN PHARMACEUTICAL CO LTD | bad73234-c204-40a8-8176-45c75ae500c8 | 2024-10-07 | Warnings | M |
| HYSAN ANALGESIC | METHYL SALICYLATE, CAMPHOR (SYNTHETIC) | HYSAN PHARMACEUTICAL CO LTD | 99a13b0a-1d77-479e-ba99-2cfa638de339 | 2024-10-04 | Warnings | M |
| HYSAN HUO LU MEDICATED | METHYL SALICYLATE, CAMPHOR (SYNTHETIC) | HYSAN PHARMACEUTICAL CO LTD | fe9eeaff-fcbf-4287-9f17-bcf1822bf35b | 2024-10-04 | Warnings | M |
| HYSAN HUA TUO MEDICATED | METHYL SALICYLATE | HYSAN PHARMACEUTICAL CO LTD | b84c4d33-5a77-46e0-b04e-32f73967bd1c | 2024-10-04 | Warnings | M |
| HYSAN HUA TUO HUO LU | METHYL SALICYLATE, CAMPHOR (SYNTHETIC) | HYSAN PHARMACEUTICAL CO LTD | cd2288c4-9909-43c1-91da-b15545b09788 | 2024-10-04 | Warnings | M |
| CLARINS - ROLL-ON DEODORANT Aluminum Chlorohydrate - Antiperspirant, Long-lasting Alcohol-free | ALUMINUM CHLOROHYDRATE | Laboratoires Clarins | 412116a1-f9af-4c03-85e0-aad5738dd797 | 2024-08-05 | Warnings | M |
| BRONCOCHEM MAXIMUM COUGH NIGHT | DEXTROMETHORPHAN HBR-PYRILAMINE MALEATE | LABORATORIO MAGNACHEM INTERNATIONAL SRL | 1a3ed214-e09b-4266-b68b-39e7c3127d26 | 2024-04-22 | Warnings | M |
| CLARUS Antifungal | TOLNAFTATE | Clinical Therapeutic Solutions | 835c3c23-fc3c-404e-8e87-5a0176126730 | 2024-02-28 | Warnings | M |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 313782 | acetaminophen 325 MG Oral Tablet | PSN | 05a91d24-b498-4ba2-a275-68b871cf62d2 | 3 |
| 1298830 | Pharbetol Regular Strength 325 MG Oral Tablet | PSN | 05a91d24-b498-4ba2-a275-68b871cf62d2 | 3 |
| 1298830 | acetaminophen 325 MG Oral Tablet [Pharbetol] | SBD | 05a91d24-b498-4ba2-a275-68b871cf62d2 | 3 |
| 313782 | acetaminophen 325 MG Oral Tablet | SCD | 05a91d24-b498-4ba2-a275-68b871cf62d2 | 3 |
| 313782 | APAP 325 MG Oral Tablet | SY | 05a91d24-b498-4ba2-a275-68b871cf62d2 | 3 |
| 1298830 | APAP 325 MG Oral Tablet [Pharbetol] | SY | 05a91d24-b498-4ba2-a275-68b871cf62d2 | 3 |
| 1298830 | Pharbetol 325 MG Oral Tablet | SY | 05a91d24-b498-4ba2-a275-68b871cf62d2 | 3 |
| 313782 | acetaminophen 325 MG Oral Tablet | PSN | bd26081c-e81e-42e8-b3da-2813863a51df | 1 |
| 1298830 | Pharbetol Regular Strength 325 MG Oral Tablet | PSN | bd26081c-e81e-42e8-b3da-2813863a51df | 1 |
| 1298830 | acetaminophen 325 MG Oral Tablet [Pharbetol] | SBD | bd26081c-e81e-42e8-b3da-2813863a51df | 1 |
| 313782 | acetaminophen 325 MG Oral Tablet | SCD | bd26081c-e81e-42e8-b3da-2813863a51df | 1 |
| 313782 | APAP 325 MG Oral Tablet | SY | bd26081c-e81e-42e8-b3da-2813863a51df | 1 |
| 1298830 | APAP 325 MG Oral Tablet [Pharbetol] | SY | bd26081c-e81e-42e8-b3da-2813863a51df | 1 |
| 1298830 | Pharbetol 325 MG Oral Tablet | SY | bd26081c-e81e-42e8-b3da-2813863a51df | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 17856-0353-1 | 17856035301 | 100 POUCH in 1 BOX, UNIT-DOSE (17856-0353-1) / 1 TABLET in 1 POUCH (17856-0353-2) | 100 pouch | 2024-06-26 | 0000-00-00 | No | No | Current |
| 17856-0353-2 | 17856035302 | 1 in 1 POUCH | Historical | |||||
| 17856-0353-3 | 17856035303 | 28 in 1 BOTTLE | Historical | |||||
| 17856-0353-4 | 17856035304 | 24 TABLET in 1 BOTTLE (17856-0353-4) | 24 tablet | 2024-06-26 | No | No | Current |